Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs FDC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA FDC AJANTA PHARMA/
FDC
 
P/E (TTM) x 23.4 28.8 81.3% View Chart
P/BV x 4.8 2.5 195.1% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 AJANTA PHARMA   FDC
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
FDC
Mar-22
AJANTA PHARMA/
FDC
5-Yr Chart
Click to enlarge
High Rs1,614405 398.7%   
Low Rs1,089249 437.0%   
Sales per share (Unadj.) Rs391.190.5 432.1%  
Earnings per share (Unadj.) Rs83.412.8 651.6%  
Cash flow per share (Unadj.) Rs98.115.0 653.3%  
Dividends per share (Unadj.) Rs9.500-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs382.1115.9 329.6%  
Shares outstanding (eoy) m85.42168.81 50.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.6 95.6%   
Avg P/E ratio x16.225.5 63.4%  
P/CF ratio (eoy) x13.821.8 63.3%  
Price / Book Value ratio x3.52.8 125.4%  
Dividend payout %11.40-   
Avg Mkt Cap Rs m115,43355,201 209.1%   
No. of employees `000NANA-   
Total wages/salary Rs m6,4583,433 188.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,41015,279 218.7%  
Other income Rs m1,157761 152.0%   
Total revenues Rs m34,56716,040 215.5%   
Gross profit Rs m9,2932,537 366.3%  
Depreciation Rs m1,253373 335.9%   
Interest Rs m10231 330.1%   
Profit before tax Rs m9,0952,894 314.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,968732 268.8%   
Profit after tax Rs m7,1272,162 329.7%  
Gross profit margin %27.816.6 167.5%  
Effective tax rate %21.625.3 85.5%   
Net profit margin %21.314.1 150.8%  
BALANCE SHEET DATA
Current assets Rs m24,54814,184 173.1%   
Current liabilities Rs m8,3776,904 121.3%   
Net working cap to sales %48.447.6 101.6%  
Current ratio x2.92.1 142.6%  
Inventory Days Days42313 13.4%  
Debtors Days Days11196 5.7%  
Net fixed assets Rs m19,25916,195 118.9%   
Share capital Rs m172169 101.7%   
"Free" reserves Rs m32,46919,399 167.4%   
Net worth Rs m32,64019,568 166.8%   
Long term debt Rs m167 251.5%   
Total assets Rs m43,80730,379 144.2%  
Interest coverage x90.294.7 95.3%   
Debt to equity ratio x00 150.8%  
Sales to assets ratio x0.80.5 151.6%   
Return on assets %16.57.2 228.6%  
Return on equity %21.811.0 197.7%  
Return on capital %28.214.9 188.5%  
Exports to sales %00-   
Imports to sales %03.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA552 0.0%   
Fx inflow Rs m18,6782,138 873.5%   
Fx outflow Rs m3,662552 663.5%   
Net fx Rs m15,0161,586 946.6%   
CASH FLOW
From Operations Rs m5,6201,617 347.7%  
From Investments Rs m-741-1,446 51.3%  
From Financial Activity Rs m-4,600-98 4,676.6%  
Net Cashflow Rs m27973 382.5%  

Share Holding

Indian Promoters % 70.5 69.5 101.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.4 10.8 198.5%  
FIIs % 8.2 4.0 206.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 30.5 96.8%  
Shareholders   62,048 63,172 98.2%  
Pledged promoter(s) holding % 17.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on AJANTA PHARMA vs FDC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs FDC Share Price Performance

Period AJANTA PHARMA FDC S&P BSE HEALTHCARE
1-Day 0.90% 4.11% 0.33%
1-Month -2.31% -1.96% 0.28%
1-Year -11.48% 0.95% -6.55%
3-Year CAGR 21.94% 14.62% 20.31%
5-Year CAGR 6.26% 6.98% 10.96%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the FDC share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of FDC the stake stands at 69.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of FDC.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

FDC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of FDC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.